Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Civil Litigation topic

No spam. Unsubscribe anytime.

Senate amends litigation standard for ethylene oxide cases, requires more specificity in complaints

3571500 · February 24, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Senate Bill 266 changes pleading standards and evidence thresholds in lawsuits involving ethylene oxide exposure, revising the standard of proof and adding complaint-specificity requirements; the Senate passed the measure after floor amendment.

SALT LAKE CITY — The Utah Senate amended and passed legislation affecting civil litigation over ethylene oxide exposure in the state’s medical device and sterilization industries.

Sen. Collymore sponsored Senate Bill 266 and moved an amendment that changed the burden-of-proof language in the draft from a "clear and convincing" standard to a "preponderance of the evidence" standard, aligning it more closely with ordinary civil litigation, the sponsor said.

On the floor, Collymore and other backers framed the bill as a measure to protect health-care supply chains and medical-device sterilization processes while preserving plaintiffs’ ability to sue. The sponsor described ethylene oxide as an essential sterilant for many medical devices and said the bill does not provide blanket immunity but requires complaints to include more detailed, credible scientific allegations and specific damages claims before they proceed.

The amended bill also includes provisions intended to reduce meritless claims by requiring a higher level of factual specificity in initial complaints. Supporters said the changes would protect manufacturers from disruptive litigation that could jeopardize sterilized medical supplies while preserving legal recourse for legitimately injured parties.

After floor debate and adoption of the sponsor’s amendment, the Senate passed the bill. The clerk announced a tally of 21 yea votes, 2 nay votes, and 6 absent. The bill will be transmitted to the House for further consideration.

Context: Sponsors emphasized balancing public health needs (continued availability of sterilized medical supplies) and access to courts for plaintiffs. Critics on the floor were not prominent in the recorded remarks; the sponsor acknowledged the bill does not grant blanket immunity and defended the change in standard as aligning with civil practice.